Hydrofluoroalkane(HFA)-versus chlorofluorocarbon(CFC)-beclomethasone dipropionate(BDP) delivery using new aerosol chambers for neonatal inhaled glucocorticoid delivery

被引：0

作者：

Cole, CH

Mitchell, JP

Foley, MP

Nagel, MW

Doyle, CC

Bates, SL

机构：

[1] Tufts Univ New England Med Ctr, Boston, MA 02111 USA

[2] Trudell Med Int, London, ON, Canada

来源：

PEDIATRIC RESEARCH | 2002年 / 51卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

2296

引用

页码：394A / 395A

页数：2

共 6 条

[1] Comparison of hydrofluoroalkane (HFA)- and chlorofluorocarbon (CFC)-inhaled glucocorticoid formulations for aerosol particle size and delivery efficiency in a neonatal model
Cole, CH
Mitchell, JP
Foley, M
Nagel, M
Doyle, C
Bates, SL
[J]. PEDIATRIC RESEARCH, 2002, 51 (04) : 356A - 356A
[2] Hydrofluoroalkane-beclomethasone versus chlorofluorocarbon-beclomethasone delivery in neonatal models
Cole, CH
Mitchell, JP
Foley, MP
Nagel, MW
[J]. ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 2004, 89 (05): : F417 - F418
[3] Long-term safety of beclomethasone dipropionate (BDP) with new HFA-BDP extrafine aerosol
Cohen, RM
Vogel, J
Hawkinson, R
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1998, 101 (01) : S64 - S64
[4] QVAR - Beclomethasone dipropionate HFA inhalation aerosol - 3M Pharmaceuticals - CFC-free form of inhaled corticosteroid
不详
[J]. FORMULARY, 2000, 35 (11) : 872 - 872
[5] Esophageal candidiasis as a side effect of inhaled fluticasone propionate dry powder: recovery by switching over to hydrofluoroalkane-134a beclomethasone dipropionate (HFA-BDP)
Kobayashi, Y.
Yasuba, H.
Kudou, M.
Hamada, K.
Kita, H.
[J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2006, 44 (05) : 193 - 197
[6] Albuterol delivery in a neonatal ventilated lung model: Nebulization versus chlorofluorocarbon- and hydrofluoroalkane-pressurized metered dose inhalers
Lugo, RA
Kenney, JK
Keenan, J
Salyer, JW
Ballard, J
Ward, RM
[J]. PEDIATRIC PULMONOLOGY, 2001, 31 (03) : 247 - 254

← 1 →